Log in to save to my catalogue

Magnesium Modifies the Cardiovascular Mortality Risk Associated with Hyperphosphatemia in Patients U...

Magnesium Modifies the Cardiovascular Mortality Risk Associated with Hyperphosphatemia in Patients U...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1640859671

Magnesium Modifies the Cardiovascular Mortality Risk Associated with Hyperphosphatemia in Patients Undergoing Hemodialysis: A Cohort Study

About this item

Full title

Magnesium Modifies the Cardiovascular Mortality Risk Associated with Hyperphosphatemia in Patients Undergoing Hemodialysis: A Cohort Study

Publisher

United States: Public Library of Science

Journal title

PloS one, 2014-12, Vol.9 (12), p.e116273-e116273

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

In vitro studies have shown inhibitory effects of magnesium (Mg) on phosphate-induced calcification of vascular smooth muscle cells, raising the possibility that maintaining a high Mg level may be useful for reducing cardiovascular risks of patients with hyperphosphatemia. We examined how serum Mg levels affect the association between serum phospha...

Alternative Titles

Full title

Magnesium Modifies the Cardiovascular Mortality Risk Associated with Hyperphosphatemia in Patients Undergoing Hemodialysis: A Cohort Study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1640859671

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1640859671

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0116273

How to access this item